Cannabidiol (CBD), a Cannabis sativa constituent, is a pharmacologically broad-spectrum
drug that in recent years has drawn increasing interest as a treatment for a range of …

Background: Numerous physical, psychological, and emotional benefits have been
attributed to marijuana since its first reported use in 2,600 BC in a Chinese pharmacopoeia …

Cannabidiol (CBD) is a major phytocannabinoid present in the Cannabis sativa plant. It
lacks the psychotomimetic and other psychotropic effects that the main plant compound Δ 9 …

Multiple cannabinoids derived from the marijuana plant have potential therapeutic benefits
but most have not been well investigated, despite the widespread legalization of medical …

Learning to associate cues or contexts with potential threats or rewards is adaptive and
enhances survival. Both aversive and appetitive memories are therefore powerful drivers of …

Anxiety and depression are pathologies that affect human beings in many aspects of life,
including social life, productivity and health. Cannabidiol (CBD) is a constituent non …

OBJECTIVES: To review and describe studies of the non-psychotomimetic constituent of
Cannabis sativa, cannabidiol (CBD), as an anxiolytic drug and discuss its possible …

This study evaluated the effects of cannabidiol (CBD) on ethanol reinforcement, motivation
and relapse in C57BL/6 J mice. The effects of CBD (60 mg/kg, ip) on blood ethanol …

Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis Sativa, has
garnered increasing attention for its diverse therapeutic potential. This comprehensive …

The prelimbic division (PrL) of the medial prefrontal cortex (mPFC) is a cerebral division that
is putatively implicated in the chronic pain and depression. We investigated the activity of …